Tirzepatide (LY3298176) Acetate (2023788-19-2 free base) is a new molecule that can control bloodglucose levels by combining dual agonism ofglucose-dependent insulinotropic polypeptide (GIP) andglucagon-like peptide-1 (GLP-1) receptors.[3]